CBFB
Core-binding factor subunit beta
Also known as: PEBB_HUMAN, PEBP2B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13951
- Gene
- CBFB
- Ensembl
- ENSG00000067955
- Chromosome
- 16
- Canonical length
- 182 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is the beta subunit of a heterodimeric core-binding transcription factor belonging to the PEBP2/CBF transcription factor family which master-regulates a host of genes specific to hematopoiesis (e.g., RUNX1) and osteogenesis (e.g., RUNX2). The beta subunit is a non-DNA binding regulatory subunit; it allosterically enhances DNA binding by alpha subunit as the complex binds to the core site of various enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers and GM-CSF promoters. Alternative splicing generates two mRNA variants, each encoding a distinct carboxyl terminus. In some cases, a pericentric inversion of chromosome 16 [inv(16)(p13q22)] produces a chimeric transcript consisting of the N terminus of core-binding factor beta in a fusion with the C-terminal portion of the smooth muscle myosin heavy chain 11. This chromosomal rearrangement is associated with acute myeloid leukemia of the M4Eo subtype. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
182 residues, UniProt reviewed canonical sequence.
>Q13951|CBFB
1 MPRVVPDQRS KFENEEFFRK LSRECEIKYT GFRDRPHEER QARFQNACRD GRSEIAFVAT
61 GTNLSLQFFP ASWQGEQRQT PSREYVDLER EAGKVYLKAP MILNGVCVIW KGWIDLQRLD
121 GMGCLEFDEE RAQQEDALAQ QAFEEARRRT REFEDRDRSH REEMEVRVSQ LLAVTGKKTT
181 RPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CBFB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- appendix: 16 nTPM
- lymph node: 15 nTPM
- skeletal muscle: 15 nTPM
- stomach: 14 nTPM
- spleen: 13 nTPM
- thymus: 13 nTPM
Single-cell type
- choroid plexus epithelial cells: 296 nCPM
- monocyte progenitors: 172 nCPM
- pituicytes/fscs: 170 nCPM
- neutrophil progenitors: 164 nCPM
- microglia: 159 nCPM
- thymic myoid cells: 159 nCPM
Immune cell
- basophil: 29 nTPM
- NK-cell: 18 nTPM
- myeloid DC: 10 nTPM
- intermediate monocyte: 9.6 nTPM
- classical monocyte: 7.7 nTPM
- naive B-cell: 7.3 nTPM
Brain region
- white matter: 46 nTPM
- medulla oblongata: 42 nTPM
- basal ganglia: 37 nTPM
- pons: 33 nTPM
- thalamus: 32 nTPM
- cerebellum: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CBFB.
Disease | AllUniProt
Conditions CBFB is implicated in, by any mechanism.
- Cleidocranial dysplasia 2 (CLCD2) MIM:620099
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 36 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cleidocranial dysplasia 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 1.71
- DepMap mean gene effect
- -0.26
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell maturation
- definitive hemopoiesis
- lymphocyte differentiation
- myeloid cell differentiation
- negative regulation of CD4-positive, alpha-beta T cell differentiation
- negative regulation of transcription by RNA polymerase II
- osteoblast differentiation
- positive regulation of CD8-positive, alpha-beta T cell differentiation
- positive regulation of transcription by RNA polymerase II
- protein polyubiquitination
- regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Core-binding factor, beta subunit
- Core-binding factor, beta subunit superfamily
- Core binding factor beta subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CBFB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CBFB as an antibody target. Whether an autoantibody or antibody against CBFB could matter depends on whether native CBFB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CBFB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CBFB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...